News

Shining bright together – Uniogen and Lumito sharing a stand at Medica

23.10.2024
Lumito has developed a ground-breaking histopathological tissue analysis solution called SCIZYS. The detection of the tissue samples is partly based…
Read more

Uniogen´s Ovarian Cancer test now a part of AMPlify program

1.10.2024
In August the company was accepted into the AMPlify program (an accelerated market entry platform), which is organized in collaboration…
Read more

Meet our Oncology Clinical Manager Kaisa Huhtinen

9.9.2024
Kaisa Huhtinen, Uniogen´s Oncology Clinical Manager, has a deep understanding of ovarian cancer diagnostics as a PhD and an Associate…
Read more

Uniogen Sustainability Achievements 2023

30.5.2024
Uniogen’s commitment to environmental, social, and governance (ESG) principles has never been stronger, as demonstrated in our 2023 Sustainability report.…
Read more

Insights from UPCON 2024, analytica, and ESCMID Global

14.5.2024
April was an exciting month for Uniogen, filled with significant participation at three major global congresses that align closely with…
Read more

Explore the future of lateral flow assays with Upcon™ upconverting nanoparticles

14.5.2024
Upcon™ upconverting nanoparticle (UCNP) system is breaking new ground in the world of diagnostics. This advanced detection technology utilizes photon…
Read more

Uniogen featured in Yle, the Finnish Broadcasting Company, news

8.3.2024
Uniogen has been featured in Finland’s national public broadcasting company news for developing a blood test that could significantly speed…
Read more

Uniogen’s April Event Schedule: ECCMID, Analytica, and UPCON 2024

8.3.2024
As spring blooms, Uniogen is gearing up for a dynamic April, packed with participation in three significant events: UPCON 2024…
Read more

Uniogen GenomEra GBS Assay Kit: an easy solution for GBS testing

8.3.2024
Antti-Heikki Tapio, a member of Uniogen’s R&D team, shares his inspiring journey in biotechnology and the background of the GenomEra…
Read more

Uniogen joins climate program: demonstrating environmental commitment

8.3.2024
Uniogen has been selected to participate in a climate program led by The Finland Chamber of Commerce and supported by…
Read more

Explore the science behind breakthroughs: a list of publications of our advanced cancer diagnostic platform now available

29.2.2024
Uniogen’s cancer diagnostic platform is based on research conducted and published at the University of Turku. Studies show that the…
Read more

Uniogen receives prestigious Seal Of Excellence from EIC for innovative cancer diagnostics solution 

19.12.2023
Uniogen has achieved a remarkable milestone by receiving the esteemed Seal of Excellence from the European Innovation Council (EIC). This…
Read more

Abacus Diagnostica, Kaivogen and Labrox are now Uniogen

Uniogen is a global pioneer in clinical diagnostics, point-of-care testing, and instrumentation for life sciences.

Uniogen – Enabling diagnosis and care at first appointment